Injectable Targets Décolleté Wrinkles - Scorecard - MDSpire

Injectable Targets Décolleté Wrinkles

  • By

  • Kathryn Wighton

  • April 10, 2026

  • 2 min

Share

Clinical Scorecard: Injectable Targets Décolleté Wrinkles

At a Glance

CategoryDetail
ConditionWrinkles in the décolleté area
Key MechanismsBiostimulation promoting collagen, elastin, and structural protein production
Target PopulationPatients aged 22 years and older
Care SettingCosmetic dermatology and aesthetic treatment settings

Key Highlights

  • RADIESSE dermal filler approved by FDA for décolleté wrinkle treatment in patients 22+ years
  • Effects last up to 2 years by enhancing dermal integrity through collagen and elastin production
  • High patient satisfaction with over 80% reporting improved skin tightness and interest in repeat treatments

Guideline-Based Recommendations

Diagnosis

  • Assessment of wrinkles and skin laxity in the décolleté area suitable for injectable treatment

Management

  • Use RADIESSE dermal filler as a biostimulator to improve skin firmness and smoothness
  • Avoid use in patients with allergies to product components, severe allergic reaction history, or bleeding disorders
  • Do not use in anatomical areas where safety is not established, such as lips and periorbital region

Monitoring & Follow-up

  • Monitor for adverse events including bruising, redness, swelling, pain, itching, difficulty chewing, and nodules
  • Be vigilant for signs of unintentional intravascular injection which may cause vision abnormalities or stroke

Risks

  • Potential adverse events at injection site including bruising and nodules
  • Serious complications from intravascular injection such as vision abnormalities and stroke
  • Contraindicated in pregnant or breastfeeding patients and those under 22 years for décolleté indication

Patient & Prescribing Data

Patients aged 22 years and older seeking treatment for décolleté wrinkles

More than 80% patient satisfaction with skin tightness; 83% likely to repeat treatment after 1 year; 93% interested in additional treatments

Clinical Best Practices

  • Confirm patient eligibility including age and absence of contraindications before treatment
  • Educate patients on expected outcomes and potential adverse events
  • Use proper injection techniques to minimize risk of intravascular injection
  • Schedule follow-up to assess treatment efficacy and monitor for adverse effects

References

Original Source(s)

Related Content